Cyteir Therapeutics
Cyteir Therapeutics
cyteir.com

Locations

Cambridge, MA, USA · Lexington, MA, USA · Cambridge, MA, USA

industry

Biotechnology · DeepTech · Health

Size

1 - 10 employees

Stage

Series C+

founded in

2012

Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir’s wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug that was designed to inhibit RAD51-mediated homologous recombination and the repair of double-strand DNA breaks.

Something looks off?
Open jobs at Cyteir Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.